The client is one of the world’s largest biopharmaceutical companies that develops, manufactures and markets pharmaceutical drugs in more than 100 countries worldwide.
The Project Objective
The overall objective of this project was to assess the current End-to-End Labeling processes, roles and responsibilities and technologies, compare these to industry best practices, and then design and implement a robust and systemically compliant ‘To-Be’ solution.
Learn how Navitas Life Sciences helped the client achieve:
- A redefined labeling department with clear roles and responsibilities
- Rationalized and simplified labeling governance bodies accompanied by the enhancement of a Quality Management System for labelling
- An integrated single process, applicable to medicinal products, combination products and biosimilars